Increased	VBN	increase VBN PennPOS
expression	NN	expression NN PennPOS
of	IN	of pp-f NUPOS
5-hydroxytryptamine2A	NN	5-hydroxytryptamine2A NN PennPOS
/	:	/ : NUPOS
B	NN	b NN PennPOS
receptors	NNS	receptor NNS PennPOS
in	IN	in IN PennPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
:	:	: : NUPOS
a	DT	a dt NUPOS
rationale	NN	rationale NN PennPOS
for	IN	for c-acp NUPOS
therapeutic	JJ	therapeutic JJ PennPOS
intervention	NN	intervention NN PennPOS
.	.	. . NUPOS

BACKGROUND	NN	background NN PennPOS
:	:	: : NUPOS
Idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
has	VBZ	have vdz NUPOS
a	DT	a dt NUPOS
poor	JJ	poor JJ PennPOS
prognosis	NN	prognosis NN PennPOS
and	CC	and cc NUPOS
limited	JJ	limited JJ PennPOS
responsiveness	NN	responsiveness NN PennPOS
to	TO	to p-acp NUPOS
available	JJ	available JJ PennPOS
treatments	NNS	treatment NNS PennPOS
.	.	. . NUPOS

It	PRP	it pn31 NUPOS
is	VBZ	be vbz NUPOS
characterised	VBN	characterize VBN PennPOS
by	IN	by IN PennPOS
epithelial	JJ	epithelial JJ PennPOS
cell	NN	cell NN PennPOS
injury	NN	injury NN PennPOS
,	,	, , NUPOS
fibroblast	NN	fibroblast NN PennPOS
activation	NN	activation NN PennPOS
and	CC	and cc NUPOS
proliferation	NN	proliferation NN PennPOS
and	CC	and cc NUPOS
extracellular	JJ	extracellular JJ PennPOS
matrix	NN	matrix NN PennPOS
deposition	NN	deposition NN PennPOS
.	.	. . NUPOS

Serotonin	NN	serotonin NN PennPOS
(	(	( ( NUPOS
5-hydroxytryptamine	NN	5-hydroxytryptamine NN PennPOS
;	:	; : NUPOS
5-HT	NN	5-HT NN PennPOS
)	)	) ) NUPOS
induces	VBZ	induce VBZ PennPOS
fibroblast	NN	fibroblast NN PennPOS
proliferation	NN	proliferation NN PennPOS
via	IN	via IN PennPOS
the	DT	the dt NUPOS
5-HTR	NN	5-HTR NN PennPOS
(	(	( ( NUPOS
2A	NN	2A NN PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
5-HTR	NN	5-HTR NN PennPOS
(	(	( ( NUPOS
2B	NN	2B NN PennPOS
)	)	) ) NUPOS
receptors	NNS	receptor NNS PennPOS
,	,	, , NUPOS
but	CC	but cc-acp NUPOS
its	PRP$	its po31 NUPOS
pathophysiological	JJ	pathophysiological JJ PennPOS
role	NN	role NN PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
remains	VBZ	remain VBZ PennPOS
unclear	JJ	unclear JJ PennPOS
.	.	. . NUPOS

A	DT	a dt NUPOS
study	NN	study NN PennPOS
was	VBD	be vbd NUPOS
undertaken	VBN	undertake VBN PennPOS
to	TO	to p-acp NUPOS
determine	VB	determine VBP PennPOS
the	DT	the dt NUPOS
expression	NN	expression NN PennPOS
of	IN	of pp-f NUPOS
5-HT	NN	5-HT NN PennPOS
receptors	NNS	receptor NNS PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
and	CC	and cc NUPOS
experimental	JJ	experimental JJ PennPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
and	CC	and cc NUPOS
to	TO	to p-acp NUPOS
investigate	VB	investigate VBP PennPOS
the	DT	the dt NUPOS
effects	NNS	effect NNS PennPOS
of	IN	of pp-f NUPOS
therapeutic	JJ	therapeutic JJ PennPOS
inhibition	NN	inhibition NN PennPOS
of	IN	of pp-f NUPOS
5-HTR	NN	5-HTR NN PennPOS
(	(	( ( NUPOS
2A/B	NN	2A/B NN PennPOS
)	)	) ) NUPOS
signalling	NN	signalling NN PennPOS
on	IN	on IN PennPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
in	FW	in fw-la NUPOS
vivo	FW	vivo fw-la NUPOS
and	CC	and cc NUPOS
in	FW	in fw-la NUPOS
vitro	FW	vitro FW PennPOS
.	.	. . NUPOS

METHODS	NNS	method NNS PennPOS
AND	CC	and cc NUPOS
RESULTS	NNS	result NNS PennPOS
:	:	: : NUPOS
Quantitative	JJ	quantitative JJ PennPOS
RT-PCR	NN	rt-pcr NN PennPOS
showed	VBD	show VBN PennPOS
that	IN	that cst NUPOS
the	DT	the dt NUPOS
expression	NN	expression NN PennPOS
of	IN	of pp-f NUPOS
5-HTR	NN	5-HTR NN PennPOS
(	(	( ( NUPOS
1A/B	NN	1A/B NN PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
5-HTR	NN	5-HTR NN PennPOS
(	(	( ( NUPOS
2B	NN	2B NN PennPOS
)	)	) ) NUPOS
was	VBD	be vbd NUPOS
significantly	RB	significant av-j NUPOS
increased	VBN	increase VBN PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
lungs	NNS	lung NNS PennPOS
of	IN	of pp-f NUPOS
patients	NNS	patient NNS PennPOS
with	IN	with pp NUPOS
IPF	NN	IPF NN PennPOS
(	(	( ( NUPOS
n	NN	n NN PennPOS
=	JJ	= JJ PennPOS
12	CD	12 crd NUPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
in	IN	in IN PennPOS
those	DT	those d NUPOS
with	IN	with pp NUPOS
non-specific	JJ	non-specific JJ PennPOS
interstitial	JJ	interstitial JJ PennPOS
pneumonia	NN	pneumonia NN PennPOS
(	(	( ( NUPOS
NSIP	NN	NSIP NN PennPOS
,	,	, , NUPOS
n	NN	n NN PennPOS
=	JJ	= JJ PennPOS
6	CD	6 crd NUPOS
)	)	) ) NUPOS
compared	VBN	compare VBN PennPOS
with	IN	with pp NUPOS
transplant	NN	transplant NN PennPOS
donors	NNS	donor NNS PennPOS
(	(	( ( NUPOS
n	NN	n NN PennPOS
=	JJ	= JJ PennPOS
12	CD	12 crd NUPOS
)	)	) ) NUPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
expression	NN	expression NN PennPOS
of	IN	of pp-f NUPOS
5-HTR	NN	5-HTR NN PennPOS
(	(	( ( NUPOS
2A	NN	2A NN PennPOS
)	)	) ) NUPOS
was	VBD	be vbd NUPOS
increased	VBN	increase VBN PennPOS
specifically	RB	specific av-j NUPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
lungs	NNS	lung NNS PennPOS
but	CC	but cc-acp NUPOS
not	RB	not xx NUPOS
in	IN	in IN PennPOS
NSIP	NNP	NSIP NNP PennPOS
lungs	NNS	lung NNS PennPOS
.	.	. . NUPOS

While	IN	while cs NUPOS
5-HTR	NN	5-HTR NN PennPOS
(	(	( ( NUPOS
2A	NN	2A NN PennPOS
)	)	) ) NUPOS
protein	NN	protein NN PennPOS
largely	RB	large av-j NUPOS
localised	JJ	localised JJ PennPOS
to	TO	to p-acp NUPOS
fibroblasts	NNS	fibroblast NNS PennPOS
,	,	, , NUPOS
5-HTR	NN	5-HTR NN PennPOS
(	(	( ( NUPOS
2B	NN	2B NN PennPOS
)	)	) ) NUPOS
localised	JJ	localised JJ PennPOS
to	TO	to p-acp NUPOS
the	DT	the dt NUPOS
epithelium	NN	epithelium NN PennPOS
.	.	. . NUPOS

To	TO	to p-acp NUPOS
assess	VB	assess VBP PennPOS
the	DT	the dt NUPOS
effects	NNS	effect NNS PennPOS
of	IN	of pp-f NUPOS
5HTR	NN	5HTR NN PennPOS
(	(	( ( NUPOS
2A/B	NN	2A/B NN PennPOS
)	)	) ) NUPOS
inhibition	NN	inhibition NN PennPOS
on	IN	on IN PennPOS
fibrogenesis	NN	fibrogenesis NN PennPOS
in	FW	in fw-la NUPOS
vivo	FW	vivo fw-la NUPOS
,	,	, , NUPOS
mice	NNS	mouse n2 NUPOS
were	VBD	be vbd NUPOS
subjected	VBN	subject VBN PennPOS
to	TO	to p-acp NUPOS
bleomycin-induced	JJ	bleomycin-induced JJ PennPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
and	CC	and cc NUPOS
treated	VBN	treat VBN PennPOS
with	IN	with pp NUPOS
the	DT	the dt NUPOS
5-HTR	NN	5-HTR NN PennPOS
(	(	( ( NUPOS
2A/B	NN	2A/B NN PennPOS
)	)	) ) NUPOS
antagonist	NN	antagonist NN PennPOS
terguride	NN	terguride NN PennPOS
(	(	( ( NUPOS
or	CC	or cc NUPOS
vehicle	NN	vehicle NN PennPOS
)	)	) ) NUPOS
in	IN	in IN PennPOS
a	DT	a dt NUPOS
therapeutic	JJ	therapeutic JJ PennPOS
approach	NN	approach NN PennPOS
(	(	( ( NUPOS
days	NNS	day n2 NUPOS
14-28	CD	14-28 CD PennPOS
after	IN	after c-acp NUPOS
bleomycin	NN	bleomycin NN PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

Terguride-treated	JJ	terguride-treated JJ PennPOS
mice	NNS	mouse n2 NUPOS
had	VBD	have vhd NUPOS
significantly	RB	significant av-j NUPOS
improved	VBN	improve VBN PennPOS
lung	NN	lung NN PennPOS
function	NN	function NN PennPOS
and	CC	and cc NUPOS
histology	NN	histology NN PennPOS
and	CC	and cc NUPOS
decreased	VBD	decrease VBD PennPOS
collagen	NN	collagen NN PennPOS
content	JJ	content JJ PennPOS
compared	VBN	compare VBN PennPOS
with	IN	with pp NUPOS
vehicle-treated	JJ	vehicle-treated JJ PennPOS
mice	NNS	mouse n2 NUPOS
.	.	. . NUPOS

Functional	JJ	functional JJ PennPOS
in	FW	in fw-la NUPOS
vitro	FW	vitro FW PennPOS
studies	NNS	study NNS PennPOS
showed	VBD	show VBN PennPOS
that	IN	that cst NUPOS
terguride	NN	terguride NN PennPOS
is	VBZ	be vbz NUPOS
a	DT	a dt NUPOS
potent	JJ	potent JJ PennPOS
inhibitor	NN	inhibitor NN PennPOS
of	IN	of pp-f NUPOS
transforming-growth-factor-b	NN	transforming-growth-factor-b NN PennPOS
(	(	( ( NUPOS
1	CD	1 crd NUPOS
)	)	) ) NUPOS
-	:	- : NUPOS
or	CC	or cc NUPOS
WNT3a-induced	JJ	wnt3a-induced JJ PennPOS
collagen	NN	collagen NN PennPOS
production	NN	production NN PennPOS
.	.	. . NUPOS

CONCLUSION	NN	conclusion NN PennPOS
:	:	: : NUPOS
The	DT	the dt NUPOS
studies	NNS	study NNS PennPOS
revealed	VBD	reveal VBD PennPOS
an	DT	a dt NUPOS
increased	VBN	increase VBN PennPOS
expression	NN	expression NN PennPOS
of	IN	of pp-f NUPOS
5-HTR	NN	5-HTR NN PennPOS
(	(	( ( NUPOS
2A	NN	2A NN PennPOS
)	)	) ) NUPOS
specifically	RB	specific av-j NUPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

Blockade	NN	blockade NN PennPOS
of	IN	of pp-f NUPOS
5-HTR	NN	5-HTR NN PennPOS
(	(	( ( NUPOS
2A/B	NN	2A/B NN PennPOS
)	)	) ) NUPOS
signalling	NN	signalling NN PennPOS
by	IN	by IN PennPOS
terguride	NN	terguride NN PennPOS
reversed	VBD	reverse VBD PennPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
and	CC	and cc NUPOS
is	VBZ	be vbz NUPOS
thus	RB	thus av NUPOS
a	DT	a dt NUPOS
promising	JJ	promising JJ PennPOS
therapeutic	JJ	therapeutic JJ PennPOS
approach	NN	approach NN PennPOS
for	IN	for c-acp NUPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

